Corvus Pharmaceuticals
CRVS
#7832
Rank
โ‚น21.10 B
Marketcap
โ‚น309.70
Share price
-0.82%
Change (1 day)
146.10%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -โ‚น5.24 Billion

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚น2.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น5.32 Billion130.47%
2023 -โ‚น2.31 Billion-34.57%
2022 -โ‚น3.53 Billion-4.47%
2021 -โ‚น3.69 Billion621.28%
2020 -โ‚น0.52 Billion-87.16%
2019 -โ‚น3.99 Billion-0.57%
2018 -โ‚น4.01 Billion-15.67%
2017 -โ‚น4.75 Billion53.03%
2016 -โ‚น3.11 Billion16.08%
2015 -โ‚น2.68 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น12.2 Billion 129.39%๐Ÿ‡บ๐Ÿ‡ธ USA